These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 15113441)
1. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852 [TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ Mol Carcinog; 2010 Jun; 49(6):545-55. PubMed ID: 20306497 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923 [TBL] [Abstract][Full Text] [Related]
7. DNA-repair genetic polymorphisms and breast cancer risk. Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer susceptibility variants alter risks in familial disease. Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217 [TBL] [Abstract][Full Text] [Related]
9. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population. Kim KY; Han W; Noh DY; Kang D; Kwack K Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439 [TBL] [Abstract][Full Text] [Related]
10. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Chacko P; Rajan B; Joseph T; Mathew BS; Pillai MR Breast Cancer Res Treat; 2005 Jan; 89(1):15-21. PubMed ID: 15666192 [TBL] [Abstract][Full Text] [Related]
12. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Jorgensen TJ; Visvanathan K; Ruczinski I; Thuita L; Hoffman S; Helzlsouer KJ Breast Cancer Res Treat; 2007 Jan; 101(1):65-71. PubMed ID: 16823510 [TBL] [Abstract][Full Text] [Related]
14. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771 [TBL] [Abstract][Full Text] [Related]
15. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991 [TBL] [Abstract][Full Text] [Related]
17. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695 [TBL] [Abstract][Full Text] [Related]
19. Disease family history and modification of breast cancer risk in common BRCA2 variants. Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416 [TBL] [Abstract][Full Text] [Related]
20. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. Hughes DJ; Ginolhac SM; Coupier I; Corbex M; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Maugard C; Olschwang S; Yannoukakos D; Durocher F; Moisan AM; Simard J; Mazoyer S; Lynch HT; Szabo C; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):265-7. PubMed ID: 15668505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]